课题基金 / 基金详情

Allosteric modulation of the urotensin receptor with small molecules

Allosteric modulation of the urotensin receptor with small molecules
小分子对尾加压素受体的变构调节
批准号:
321260
负责人:
Lubell William D
金额:
$37.61万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-03-01 至 2019-03-01

项目摘要

项目成果

Lubell William D的其他基金

相关文献

中文摘要
翻译
尿紧张素II受体(UT)在心脏、肾脏、胰腺、肾上腺和中枢神经系统中起着重要作用。已知该受体与两种内源性环肽配体结合:尿紧张素II (UII)和尿紧张素II相关肽(UII)
英文摘要
The urotensin II receptor (UT) plays important roles in the heart, kidneys, pancreas, adrenal gland, and central nervous system. The receptor is known to bind to two endogenous cyclic peptide ligands: urotensin II (UII) and urotensin II-related peptide (U
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin-1 Receptor Modulating Therapy for Treating Macular Degeneration
  • 批准号:
    478746
  • 项目类别:
    Operating Grants
  • 资助金额:
    $37.62万
  • 财政年份:
    2023
  • 负责人:
    Lubell William D
  • 依托单位:
Treating Age-Related Macular Degeneration by Mitigating Inflammation, Oxidative Stress, and Lipid Accumulation through CD36 Modulation
  • 批准号:
    468104
  • 项目类别:
    Operating Grants
  • 资助金额:
    $60.75万
  • 财政年份:
    2022
  • 负责人:
    Lubell William D
  • 依托单位:
Safe and selective anti-parasite therapy targeting ribosome and glycosome function
  • 批准号:
    451337
  • 项目类别:
    Operating Grants
  • 资助金额:
    $64.65万
  • 财政年份:
    2021
  • 负责人:
    Lubell William D
  • 依托单位:
Allosteric Modulation of the Urotensin Receptor with Small-Molecule Peptide Mimics
  • 批准号:
    407925
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.73万
  • 财政年份:
    2019
  • 负责人:
    Lubell William D
  • 依托单位: